These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1788980)

  • 1. Sex differences in excretion of zenarestat in rat.
    Tanaka Y; Deguchi Y; Ishii I; Terai T
    Xenobiotica; 1991 Sep; 21(9):1119-25. PubMed ID: 1788980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex difference in the excretion of zenarestat in mice, rats, dogs and humans.
    Tanaka Y; Fujiwara T; Esumi Y
    Xenobiotica; 1992 Aug; 22(8):941-7. PubMed ID: 1413883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution and excretion of zenarestat, a new aldose reductase inhibitor, in rats and dogs.
    Tanaka Y; Sekiguchi M; Sawamoto T; Katami Y; Ueda T; Esumi Y; Noda K
    Xenobiotica; 1992 Jan; 22(1):57-64. PubMed ID: 1615708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of age and sex hormones on the urinary excretion of zenarestat in rats.
    Tanaka Y; Kadoh Y; Mukumoto S; Ishikawa H
    Xenobiotica; 1991 Oct; 21(10):1273-9. PubMed ID: 1796605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of zenarestat, an aldose reductase inhibitor, in male and female diabetic rats.
    Tanaka Y; Sawamoto T; Suzuki A; Kimura T
    Drug Metab Dispos; 1993; 21(4):677-81. PubMed ID: 8104128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hypophysectomy and testosterone treatment on the urinary excretion of zenarestat in rats.
    Tanaka Y; Kadoh Y; Ishikawa H
    Xenobiotica; 1992 Jan; 22(1):51-5. PubMed ID: 1615707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of perfluorodecanoic acid in male and female rats.
    Vanden Heuvel JP; Kuslikis BI; Van Rafelghem MJ; Peterson RE
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):450-9. PubMed ID: 2000633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic hydrolysis of zenarestat 1-O-acylglucuronide.
    Tanaka Y; Suzuki A
    J Pharm Pharmacol; 1994 Mar; 46(3):235-9. PubMed ID: 8027935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats.
    Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the metabolites of irinotecan, a new derivative of camptothecin, in rat bile and its biliary excretion.
    Atsumi R; Suzuki W; Hakusui H
    Xenobiotica; 1991 Sep; 21(9):1159-69. PubMed ID: 1788984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-dependent and independent renal excretion of nilvadipine metabolites in rat: evidence for a sex-dependent active secretion in kidney.
    Terashita S; Sawamoto T; Deguchi S; Tokuma Y; Hata T
    Xenobiotica; 1995 Jan; 25(1):37-47. PubMed ID: 7604605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicokinetics of zenarestat, an aldose reductase inhibitor in animals and man.
    Tanaka Y; Shimojyo H; Hata T; Hashimoto M; Noguchi H
    Xenobiotica; 1994 May; 24(5):461-71. PubMed ID: 8079505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog.
    Wong BK; Woolf TF; Chang T; Whitfield LR
    Drug Metab Dispos; 1990; 18(6):980-6. PubMed ID: 1981548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic disposition of enciprazine, a non-benzodiazepine anxiolytic drug, in rat, dog and man.
    Scatina JA; Lockhead SR; Cayen MN; Sisenwine SF
    Xenobiotica; 1991 Dec; 21(12):1591-604. PubMed ID: 1686125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differences in the metabolism and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats.
    Terashita S; Tokuma Y; Sekiguchi M; Noguchi H
    Xenobiotica; 1989 Nov; 19(11):1221-9. PubMed ID: 2618076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.